Sort
40,608 grants matching “prostate cancer”
Chemistry and Biology of Platinum Anticancer Drugs
$703,653Stephen J Lippard · Massachusetts Institute Of Technology · R01 · FY2010 · CA
MOUSE CANCER MODELS BY REGULATED INACTIVATION OF TUMOR S
$703,046University Of California Irvine · U01 · FY2002 · CA
UNIQUE GENOMIC ALTERATION IN PROSTATE CANCERS IN AFRICAN AMERICAN MEN
$703,023Baylor College Of Medicine · · FY2012 · Department of Defense
Urban Latino African American Cancer Disparities Project
$702,985Michael Lee Steinberg · Daniel Freeman Memorial Hospital · U56 · FY2006 · CA
Natural Language Processing Platform for Cancer Surveillance
$702,677Guergana K. Savova · Boston Children'S Hospital · UH3 · FY2023 · CA
Development/Clinical Validation Markers for Prostate Ca
$702,609Alan W Partin · Johns Hopkins University · U01 · FY2008 · CA
Second Manhood: A Multimedia Intervention for Male Sexual Problems after Cancer
$702,587Paul Martinetti · Digital Science Technologies, Llc · R42 · FY2011 · CA
Consequences of retrotransposition on genome integrity
$702,485Kathleen H Burns · Dana-Farber Cancer Inst · R01 · FY2024 · CA
DNA Sequencing
$702,367Steven Akiyama · National Institute Of Environmental Health Sciences · ZIB · FY2011 · ES
CANCER CENTER SUPPORT GRANT
$702,299Wayne State University · P30 · FY2001 · CA
Leveraging PMN immune response to overcome ADT resistance in bone metastatic prostate cancer
$702,262Grinu Mathew · University Of Nebraska Medical Center · R01 · FY2025 · CA
BIOMARKER VALIDATION LABORATORIES
$702,240University Of Alabama At Birmingham · U24 · FY2003 · CA
Addressing the Biology of Health Disparities by Targeting Geographical Ancestry-driven Variants of Immunity
$702,174Kevin Sean Kimbro · North Carolina Central University · R01 · FY2021 · MD
THE ISOLATION AND CHARACTERIZATION OF HUMAN PROSTATE CANCER STEM CELLS
$702,000Regents Of The University Of Michigan · · FY2008 · Department of Defense
COMPUTER-AIDED DIAGNOSIS OF PROSTATE CANCER WITH MULTIPARAMETRIC MR IMAGING
$702,000University Of Chicago · · FY2010 · Department of the Army
SPECIFIC KILLING OF PROSTATE CANCERS WITH INACTIVATED RB PATHWAY
$702,000University Of Chicago · · FY2010 · Department of the Army
INVESTIGATING GENOMIC MECHANISMS OF TREATMENT RESISTANCE IN CASTRATION-RESISTANT PROSTATE CANCER
$702,000Regents Of The University Of California, San Francisco, The · · FY2012 · Department of the Army
FYN IS A KEY REGULATOR OF METASTASIS IN PROSTATE CANCER
$702,000Cedars-Sinai Medical Center · · FY2011 · Department of Defense
PROBING ANDROGEN RECEPTOR SIGNALING IN CIRCULATING TUMOR CELLS IN PROSTATE CANCER
$702,000The General Hospital Corporation · · FY2012 · Department of the Army
TARGETING THE METABOLOME AND P13K/AMPK/MTOR SIGNALING PATHWAYS IN ADVANCED PROSTATE CANCER
$701,861University Of Chicago · · FY2011 · Department of the Army
A new radiopharmaceutical for the treatment of metastatic bone cancer
$701,849Jaime Nmn Simon · Isotherapeutics Group, Llc · R44 · FY2014 · CA
CIRCULATING TUMOR CELLS AS BIOMARKERS FOR PATIENTS WITH METASTATIC PROSTATE CANCER: DEVELOPING ASSAYS FOR ANDROGEN RECEPTOR SIGNALING PATHWAY
$701,836Sloan-Kettering Institute For Cancer Research · · FY2009 · Department of the Army
Florida Hospital Cancer Institute Community Clinical Oncology Program
$701,835Lee Zehngebot · Adventhealth Orlando · U10 · FY2013 · CA
Complex Human Diseases - From Gene to Function to Therapy
$701,821Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Cancer and Inflammation - Genetics and Function
$701,821Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA